Erika L Thompson1, Christopher W Wheldon2, Brittany L Rosen3, Sarah B Maness4, Monica L Kasting5, Philip M Massey6. 1. Department of Health Behavior and Health Systems, School of Public Health, University of North Texas Health Science Center, Fort Worth, TX, United States. Electronic address: Erika.thompson@unthsc.edu. 2. Department of Social and Behavioral Sciences, College of Public Health, Temple University, Philadelphia, PA, United States. Electronic address: chris.wheldon@temple.edu. 3. Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, OH, United States. Electronic address: brittany.rosen@cchmc.org. 4. Department of Health and Exercise Science, College of Arts and Sciences, University of Oklahoma, Norman, OK, United States. Electronic address: smaness@ou.edu. 5. Department of Public Health, College of Health and Human Sciences, Purdue University, West Lafayette, IN, United States. Electronic address: mlkastin@purdue.edu. 6. Department of Community Health and Prevention, Dornsife School of Public Health, Drexel University, Philadelphia, PA, United States. Electronic address: pmm85@drexel.edu.
Abstract
OBJECTIVE: Recent guidelines indicate adults 27-45 years old can receive the human papillomavirus (HPV) vaccine based on a shared-decision with their healthcare provider. With this expansion in recommendations, there is a need to examine the awareness and knowledge of HPV and HPV vaccination among this age group for cancer prevention. METHODS: HINTS-5 Cycle-2 is a national survey of US adults, and was restricted to a complete case analysis of adults ages 27-45 years (N = 725). Sociodemographic, healthcare, and health information correlates were assessed for the outcomes of HPV awareness, HPV vaccine awareness, knowledge of HPV and cervical cancer, and knowledge of HPV and non-cervical cancers. Survey-weighted logistic regression models were conducted. RESULTS: Most respondents were aware of HPV (72.9%) and HPV vaccination (67.1%). Respondents were more likely to be aware of HPV and HPV vaccination if they were female, had a higher level of education, and had previous cancer information seeking behaviors. Although there was widespread knowledge of HPV as a cause of cervical cancer (79.6%), knowledge of HPV as a cause of non-cervical cancers was reported by a minority of respondents (36.1%). College education was positively associated with cervical cancer knowledge (aOR = 4.62; 95%CI: 1.81-11.78); however, no significant correlates were identified for non-cervical HPV associated cancer knowledge. CONCLUSION: While more than half of adults ages 27-45 years are aware of HPV and HPV vaccination, there are opportunities to improve awareness and knowledge, particularly related to non-cervical cancers, as these are critical first steps toward shared decision-making for HPV vaccination in mid-adulthood.
OBJECTIVE: Recent guidelines indicate adults 27-45 years old can receive the human papillomavirus (HPV) vaccine based on a shared-decision with their healthcare provider. With this expansion in recommendations, there is a need to examine the awareness and knowledge of HPV and HPV vaccination among this age group for cancer prevention. METHODS: HINTS-5 Cycle-2 is a national survey of US adults, and was restricted to a complete case analysis of adults ages 27-45 years (N = 725). Sociodemographic, healthcare, and health information correlates were assessed for the outcomes of HPV awareness, HPV vaccine awareness, knowledge of HPV and cervical cancer, and knowledge of HPV and non-cervical cancers. Survey-weighted logistic regression models were conducted. RESULTS: Most respondents were aware of HPV (72.9%) and HPV vaccination (67.1%). Respondents were more likely to be aware of HPV and HPV vaccination if they were female, had a higher level of education, and had previous cancer information seeking behaviors. Although there was widespread knowledge of HPV as a cause of cervical cancer (79.6%), knowledge of HPV as a cause of non-cervical cancers was reported by a minority of respondents (36.1%). College education was positively associated with cervical cancer knowledge (aOR = 4.62; 95%CI: 1.81-11.78); however, no significant correlates were identified for non-cervical HPV associated cancer knowledge. CONCLUSION: While more than half of adults ages 27-45 years are aware of HPV and HPV vaccination, there are opportunities to improve awareness and knowledge, particularly related to non-cervical cancers, as these are critical first steps toward shared decision-making for HPV vaccination in mid-adulthood.
Authors: Erika L Thompson; Annalynn M Galvin; Ashvita Garg; Jonathan D Moore; Dana M Litt Journal: Hum Vaccin Immunother Date: 2021-11-04 Impact factor: 3.452
Authors: Annalynn M Galvin; Ashvita Garg; Jonathan D Moore; Dana M Litt; Erika L Thompson Journal: Hum Vaccin Immunother Date: 2021-06-04 Impact factor: 4.526
Authors: Paul Rotert; Christopher Wheldon; Jenn Kownack; Zoe Sullivan-Blum; Brendan Cokingtin; Karishma Khetani; Kavindu Ndeti; Kevin Skyes; Megha Ramaswamy Journal: J Prim Care Community Health Date: 2022 Jan-Dec